Full name
SWISSLASER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 2,3 | 3,5 | 2,2 | -35 |
Gross profit (loss) | 0,5 | 0 | 1 | 6941,2 |
EBITDA | 0,6 | 0,3 | 1,4 | 389,1 |
Net profit (loss) | 0,5 | 0 | 0,9 | 51 917,8 |
Cash | 1 | 1,9 | 1,1 | -43,2 |
Liabilities and provisions for liabilities | 2,1 | 3,2 | 1,2 | -62,8 |
Net income from sale | 5,8 | 7,8 | 8,3 | 5,7 |
Short time liabilities | 2,1 | 3,2 | 1,2 | -62,8 |
Equity capital | 0,2 | 0,2 | 1 | 341,9 |
Working assets | 1,3 | 2,4 | 1,2 | -50,7 |
Operating profit (EBIT) | 0,5 | 0 | 1,1 | 29 132 |
Depreciation | 0,1 | 0,3 | 0,3 | 22,4 |
% | % | % | p.p. | |
Profitability of capital | 222,3 | 0,8 | 90,4 | 89,6 |
Equity capital to total assets | 9 | 6,9 | 46,7 | 39,8 |
Gross profit margin | 8,9 | 0,2 | 12,7 | 12,5 |
EBITDA Margin | 10,5 | 3,7 | 17 | 13,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 132 | 150 | 53 | -97 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane